BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30761545)

  • 1. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for
    Seo Y; Huh Y; Huang SY; Hernandez-Pampaloni JM; Hawkins RA; Gustafson WC; Vo KT; Matthay KK
    Med Phys; 2019 May; 46(5):2477-2486. PubMed ID: 30761545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
    Huang SY; Bolch WE; Lee C; Van Brocklin HF; Pampaloni MH; Hawkins RA; Sznewajs A; DuBois SG; Matthay KK; Seo Y
    Mol Imaging Biol; 2015 Apr; 17(2):284-94. PubMed ID: 25145966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
    Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
    Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
    Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA
    Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
    J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of
    Maric I; Weber M; Prochnow A; Schmitz J; Unger N; Schaarschmidt BM; Poeppel TD; Rischpler C; Bockisch A; Herrmann K; Jentzen W; Fendler WP
    J Nucl Med; 2023 Jun; 64(6):885-891. PubMed ID: 36732054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
    Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
    J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
    Trieu M; DuBois SG; Pon E; Nardo L; Hawkins RA; Marachelian A; Twist CJ; Park JR; Matthay KK
    Pediatr Blood Cancer; 2016 Mar; 63(3):436-42. PubMed ID: 26506090
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    AlSadi R; Maaz AUR; Bouhali O; Djekidel M
    J Nucl Med Technol; 2023 Jun; 51(2):140-146. PubMed ID: 37192823
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
    Taggart DR; Han MM; Quach A; Groshen S; Ye W; Villablanca JG; Jackson HA; Mari Aparici C; Carlson D; Maris J; Hawkins R; Matthay KK
    J Clin Oncol; 2009 Nov; 27(32):5343-9. PubMed ID: 19805691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.
    Pandit-Taskar N; Zanzonico P; Hilden P; Ostrovnaya I; Carrasquillo JA; Modak S
    Clin Nucl Med; 2017 Oct; 42(10):741-748. PubMed ID: 28759518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
    Lee CL; Wahnishe H; Sayre GA; Cho HM; Kim HJ; Hernandez-Pampaloni M; Hawkins RA; Dannoon SF; VanBrocklin HF; Itsara M; Weiss WA; Yang X; Haas-Kogan DA; Matthay KK; Seo Y
    Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
    Rutgers M; Buitenhuis CK; Hoefnagel CA; Voûte PA; Smets LA
    Int J Cancer; 2000 Aug; 87(3):412-22. PubMed ID: 10897048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
    Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
    Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, Treatment Response, and Prognosis: The Role of
    Piccardo A; Morana G; Puntoni M; Campora S; Sorrentino S; Zucchetta P; Ugolini M; Conte M; Cistaro A; Ferrarazzo G; Pescetto M; Lattuada M; Bottoni G; Garaventa A; Giovanella L; Lopci E
    J Nucl Med; 2020 Mar; 61(3):367-374. PubMed ID: 31541036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma.
    Buckley SE; Chittenden SJ; Saran FH; Meller ST; Flux GD
    J Nucl Med; 2009 Sep; 50(9):1518-24. PubMed ID: 19713562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Wang P; Li T; Liu Z; Jin M; Su Y; Zhang J; Jing H; Zhuang H; Li F
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3097-3106. PubMed ID: 37160439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.